{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:57:44Z","timestamp":1769111864176,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pulmonary hypertension (PH) is a serious complication of chronic obstructive pulmonary disease (COPD). While clinical guidelines recommend specific drug therapies for pulmonary arterial hypertension (PAH), these drug therapies are not recommended for PH due to lung disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a retrospective cohort study using the Optum\u00ae Clinformatics\u00ae Data Mart from January 2009\u2013September 2019. An algorithm was designed to identify adults with\u2009\u2265\u20092 ICD-9-CM or ICD-10-CM diagnosis codes for PH and with\u2009\u2265\u20092 diagnosis codes for COPD. Sensitivity analyses were conducted among subgroups of patients with evidence of a right heart catheterization (RHC) or pulmonary function test (PFT). Patient characteristics, medications used, and durations of use of PAH and COPD medications were analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 25,975 patients met the study inclusion criteria. Their mean age was 73.5 (SD 10.0) years and 63.8% were female. Medications targeting PAH were prescribed to 643 (2.5%) patients, most frequently a phosphodiesterase-5 inhibitor (2.1%) or an endothelin receptor antagonist (0.75%). Medications for COPD were prescribed to 17,765 (68.4%) patients, most frequently an inhaled corticosteroid (57.4%) or short-acting beta agonist (50.4%). The median durations of use ranged from 4.9 to 12.8\u00a0months for PAH medications, and from 0.4 to 5.9\u00a0months for COPD medications. Of the subgroup of patients with RHC (N\u2009=\u20092325), 257 (11.1%) were prescribed a PAH medication and 1670 (71.8%) used a COPD medication. Of the subgroup with a PFT (N\u2009=\u20092995), 58 (1.9%) were prescribed a PAH medication and 2100 (70.1%) a COPD medication.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients with PH associated with COPD were identified in a US administrative claims database. Very few of these patients received any of the medications recommended for PAH, and only about two thirds received medications for COPD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-022-02167-9","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T06:02:39Z","timestamp":1666072959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6524-2412","authenticated-orcid":false,"given":"Tracey J.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dena","family":"Rosen Ramey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingfeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh J.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapnil","family":"Rajpathak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ednan K.","family":"Bajwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Lautsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,18]]},"reference":[{"issue":"1","key":"2167_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67\u2013119.","journal-title":"Eur Heart J"},{"issue":"3","key":"2167_CR2","doi-asserted-by":"publisher","first-page":"1900038","DOI":"10.1183\/13993003.00038-2019","volume":"53","author":"MM Hoeper","year":"2019","unstructured":"Hoeper MM, Humbert M. The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally! Eur Respir J. 2019;53(3):1900038.","journal-title":"Eur Respir J"},{"key":"2167_CR3","doi-asserted-by":"publisher","first-page":"649512","DOI":"10.3389\/fcvm.2021.649512","volume":"8","author":"S Karnati","year":"2021","unstructured":"Karnati S, Seimetz M, Kleefeldt F, Sonawane A, Madhusudhan T, Bachhuka A, Kosanovic D, Weissmann N, Kr\u00fcger K, Erg\u00fcn S. Chronic obstructive pulmonary disease and the cardiovascular system: vascular repair and regeneration as a therapeutic target. Front Cardiovasc Med. 2021;8:649512.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"2167_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7326\/0003-4819-155-3-201108020-00008","volume":"155","author":"A Qaseem","year":"2011","unstructured":"Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Sch\u00fcnemann H, Wedzicha W, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179\u201391.","journal-title":"Ann Intern Med"},{"issue":"24","key":"2167_CR5","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1001\/jama.2019.7233","volume":"321","author":"SP Bhatt","year":"2019","unstructured":"Bhatt SP, Balte PP, Schwartz JE, Cassano PA, Couper D, Jacobs DR Jr, Kalhan R, O\u2019Connor GT, Yende S, Sanders JL, et al. Discriminative accuracy of FEV1:FVC thresholds for COPD-related hospitalization and mortality. JAMA. 2019;321(24):2438\u201347.","journal-title":"JAMA"},{"key":"2167_CR6","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.2147\/COPD.S211841","volume":"15","author":"I Blanco","year":"2020","unstructured":"Blanco I, Tura-Ceide O, Peinado VI, Barber\u00e0 JA. Updated perspectives on pulmonary hypertension in COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:1315\u201324.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"2167_CR7","doi-asserted-by":"publisher","first-page":"1801914","DOI":"10.1183\/13993003.01914-2018","volume":"53","author":"SD Nathan","year":"2019","unstructured":"Nathan SD, Barbera JA, Gaine SP, Harari S, Martinez FJ, Olschewski H, Olsson KM, Peacock AJ, Pepke-Zaba J, Provencher S, et al. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2019;53(1):1801914.","journal-title":"Eur Respir J"},{"issue":"1","key":"2167_CR8","doi-asserted-by":"publisher","first-page":"1801889","DOI":"10.1183\/13993003.01889-2018","volume":"53","author":"N Gali\u00e8","year":"2019","unstructured":"Gali\u00e8 N, Channick RN, Frantz RP, Gr\u00fcnig E, Jing ZC, Moiseeva O, Preston IR, Pulido T, Safdar Z, Tamura Y, et al. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019;53(1):1801889.","journal-title":"Eur Respir J"},{"issue":"3","key":"2167_CR9","first-page":"309","volume":"7","author":"X Chen","year":"2015","unstructured":"Chen X, Tang S, Liu K, Li Q, Kong H, Zeng X, Xie W, Wang H. Therapy in stable chronic obstructive pulmonary disease patients with pulmonary hypertension: a systematic review and meta-analysis. J Thorac Dis. 2015;7(3):309\u201319.","journal-title":"J Thorac Dis"},{"issue":"1","key":"2167_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1086\/690017","volume":"7","author":"KW Prins","year":"2017","unstructured":"Prins KW, Duval S, Markowitz J, Pritzker M, Thenappan T. Chronic use of PAH-specific therapy in World Health Organization Group III Pulmonary Hypertension: a systematic review and meta-analysis. Pulm Circ. 2017;7(1):145\u201355.","journal-title":"Pulm Circ"},{"issue":"8","key":"2167_CR11","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3346\/jkms.2013.28.8.1200","volume":"28","author":"J Park","year":"2013","unstructured":"Park J, Song JH, Park DA, Lee JS, Lee SD, Oh YM. Systematic review and meta-analysis of pulmonary hypertension specific therapy for exercise capacity in chronic obstructive pulmonary disease. J Korean Med Sci. 2013;28(8):1200\u20136.","journal-title":"J Korean Med Sci"},{"key":"2167_CR12","first-page":"415","volume":"10","author":"GB Diette","year":"2015","unstructured":"Diette GB, Dalal AA, D\u2019Souza AO, Lunacsek OE, Nagar SP. Treatment patterns of chronic obstructive pulmonary disease in employed adults in the United States. Int J Chron Obstruct Pulmon Dis. 2015;10:415\u201322.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"2167_CR13","first-page":"16","volume":"5","author":"SPE Nishi","year":"2018","unstructured":"Nishi SPE, Maslonka M, Zhang W, Kuo YF, Sharma G. Pattern and adherence to maintenance medication use in medicare beneficiaries with chronic obstructive pulmonary disease: 2008\u20132013. Chronic Obstr Pulm Dis (Miami, Fla). 2018;5(1):16\u201326.","journal-title":"Chronic Obstr Pulm Dis (Miami, Fla)"},{"issue":"7","key":"2167_CR14","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jama.2019.10241","volume":"322","author":"AI Biener","year":"2019","unstructured":"Biener AI, Decker SL, Rohde F. Prevalence and treatment of chronic obstructive pulmonary disease (COPD) in the United States. JAMA. 2019;322(7):602.","journal-title":"JAMA"},{"issue":"10","key":"2167_CR15","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1185\/03007995.2010.516284","volume":"26","author":"MS Charles","year":"2010","unstructured":"Charles MS, Blanchette CM, Silver H, Lavallee D, Dalal AA, Mapel D. Adherence to controller therapy for chronic obstructive pulmonary disease: a review. Curr Med Res Opin. 2010;26(10):2421\u20139.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"2167_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/15412555.2011.650241","volume":"9","author":"LM Cecere","year":"2012","unstructured":"Cecere LM, Slatore CG, Uman JE, Evans LE, Udris EM, Bryson CL, Au DH. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). COPD. 2012;9(3):251\u20138.","journal-title":"COPD"},{"issue":"10","key":"2167_CR17","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/ijcp.12451","volume":"68","author":"JR Covvey","year":"2014","unstructured":"Covvey JR, Mullen AB, Ryan M, Steinke DT, Johnston BF, Wood FT, Boyter AC. A comparison of medication adherence\/persistence for asthma and chronic obstructive pulmonary disease in the United Kingdom. Int J Clin Pract. 2014;68(10):1200\u20138.","journal-title":"Int J Clin Pract"},{"issue":"5","key":"2167_CR18","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1378\/chest.11-2798","volume":"142","author":"BG Boerrigter","year":"2012","unstructured":"Boerrigter BG, Bogaard HJ, Trip P, Groepenhoff H, Rietema H, Holverda S, Boonstra A, Postmus PE, Westerhof N, Vonk-Noordegraaf A. Ventilatory and cardiocirculatory exercise profiles in COPD: the role of pulmonary hypertension. Chest. 2012;142(5):1166\u201374.","journal-title":"Chest"},{"issue":"8","key":"2167_CR19","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1164\/rccm.201801-0095PP","volume":"198","author":"G Kovacs","year":"2018","unstructured":"Kovacs G, Agusti A, Barber\u00e0 JA, Celli B, Criner G, Humbert M, Sin DD, Voelkel N, Olschewski H. Pulmonary vascular involvement in chronic obstructive pulmonary disease: Is there a pulmonary vascular phenotype? Am J Respir Critical Care Med. 2018;198(8):1000\u201311.","journal-title":"Am J Respir Critical Care Med"},{"issue":"8","key":"2167_CR20","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1111\/crj.12917","volume":"12","author":"A Mendy","year":"2018","unstructured":"Mendy A, Forno E, Niyonsenga T, Carnahan R, Gasana J. Prevalence and features of asthma-COPD overlap in the United States 2007\u20132012. Clin Respir J. 2018;12(8):2369\u201377.","journal-title":"Clin Respir J"},{"issue":"9","key":"2167_CR21","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1513\/AnnalsATS.201809-607OC","volume":"16","author":"JA Krishnan","year":"2019","unstructured":"Krishnan JA, Nibber A, Chisholm A, Price D, Bateman ED, Bjermer L, van Boven JFM, Brusselle G, Costello RW, Dandurand RJ, et al. Prevalence and characteristics of asthma-chronic obstructive pulmonary disease overlap in routine primary care practices. Ann Am Thorac Soc. 2019;16(9):1143\u201350.","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"2167_CR22","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00408-014-9609-2","volume":"192","author":"MC Mirabelli","year":"2014","unstructured":"Mirabelli MC, Beavers SF, Chatterjee AB. Active asthma and the prevalence of physician-diagnosed COPD. Lung. 2014;192(5):693\u2013700.","journal-title":"Lung"},{"issue":"1","key":"2167_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1378\/chest.11-3241","volume":"144","author":"AD Poms","year":"2013","unstructured":"Poms AD, Turner M, Farber HW, Meltzer LA, McGoon MD. Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis. Chest. 2013;144(1):169\u201376.","journal-title":"Chest"},{"issue":"7","key":"2167_CR24","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1513\/AnnalsATS.201810-672CME","volume":"16","author":"SC Mathai","year":"2019","unstructured":"Mathai SC, Hemnes AR, Manaker S, Anguiano RH, Dean BB, Saundankar V, Classi P, Nelsen AC, Gordon K, Ventetuolo CE. Identifying patients with pulmonary arterial hypertension using administrative claims algorithms. Ann Am Thorac Soc. 2019;16(7):797\u2013806.","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"2167_CR25","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1080\/15412555.2017.1336209","volume":"14","author":"SK Medrek","year":"2017","unstructured":"Medrek SK, Sharafkhaneh A, Spiegelman AM, Kak A, Pandit LM. Admission for COPD exacerbation is associated with the clinical diagnosis of pulmonary hypertension: results from a retrospective longitudinal study of a veteran population. COPD. 2017;14(5):484\u20139.","journal-title":"COPD"},{"issue":"4","key":"2167_CR26","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.chest.2018.11.004","volume":"155","author":"KR Gillmeyer","year":"2019","unstructured":"Gillmeyer KR, Lee MM, Link AP, Klings ES, Rinne ST, Wiener RS. Accuracy of algorithms to identify pulmonary arterial hypertension in administrative data: a systematic review. Chest. 2019;155(4):680\u20138.","journal-title":"Chest"},{"issue":"4","key":"2167_CR27","doi-asserted-by":"publisher","first-page":"204589402096171","DOI":"10.1177\/2045894020961713","volume":"10","author":"VP Sprecher","year":"2020","unstructured":"Sprecher VP, Didden EM, Swerdel JN, Muller A. Evaluation of code-based algorithms to identify pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients in large administrative databases. Pulm Circ. 2020;10(4):2045894020961713.","journal-title":"Pulm Circ"},{"issue":"1","key":"2167_CR28","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1186\/s12913-019-4574-3","volume":"19","author":"H Gothe","year":"2019","unstructured":"Gothe H, Rajsic S, Vukicevic D, Schoenfelder T, Jahn B, Geiger-Gritsch S, Brixner D, Popper N, Endel G, Siebert U. Algorithms to identify COPD in health systems with and without access to ICD coding: a systematic review. BMC Health Serv Res. 2019;19(1):737.","journal-title":"BMC Health Serv Res"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-02167-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-022-02167-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-02167-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T06:02:49Z","timestamp":1666072969000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-022-02167-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2167"],"URL":"https:\/\/doi.org\/10.1186\/s12890-022-02167-9","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,18]]},"assertion":[{"value":"21 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data were accessed in compliance with US patient confidentiality requirements, including the Health Insurance Portability and Accountability Act of 1996 regulations (HIPAA). All databases used are de-identified and fall under the US Department of Health and Human Services Policy for the Protection of Human Subjects, and therefore informed consent and Institutional Review Board approval were not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ USA and may own stock in Merck & Co., Inc., Rahway, NJ USA.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"383"}}